Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 203.18

-1.4%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Machaon who wrote (28490)	3/9/1999 4:56:00 PM
From: Cheryl Galt	Read Replies (1) of 32384

I emailed two main questions to IR on March first, At that time, Pam Wallace immediately responded, "I have forwarded questions 2 and 3 to the office of Dr. Steven Reich, Senior Vice President, Clinical Research." ---------------- Here's my Question #3: Ligand has said they plan to file an NDA application for Targretin for CTCL early this year. o Is that still the plan? o Has the FDA granted Ligand Orphan Drug status for Targretin for CTCL? I checked the FDA's list of Orphan Drug designates at fda.gov and Targretin was not on the list. o Is this an oversight on the part of the FDA? --------------------- Today, Ms Wallace responded: "We plan to file Targretin capsules for CTCl in the first part of this year. We do not at this time have Orphan Drug Status." --------------------- Had I been phoning, I'd have asked if they expected to file for it, or if they expected instead, to try to get expedited handling of Targretin for ABC. If any of you phone IR, please ask. Cheryl

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next